| TYFEGRA ASTRAZENECA AB
1706715 11 Dec 2014 | on 20 Aug 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective. | | | TYFEGRAL ASTRAZENECA AB
1706716 11 Dec 2014 | on 20 Aug 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective. | | 
